Amygdala connectivity predicts ketamine treatment response among patients (cont)

Re:Amygdala connectivity predicts ketamine treatment respons... by chimeracoder on Monday November 28, 2022 @01:56PM (#33777887)

> Ketamine is normally dosed based on body weight[0]. For depression IV, the dose is 0.1–0.75mg/kg/40mins, most commonly 0.5mg/kg/40mins

If we're being specific, the FDA-approved treatment of ketamine for depression is a fixed 84mg dose. It is not adjusted for body weight.

(I did invite irony by saying that it wasn't a typo - it's 84 and 56 for redoing, not 86 and 54).

[ Parent | on HN ]

Re:Amygdala connectivity predicts ketamine treatment respons... by csnover on Tuesday November 29, 2022 @11:28PM (#33797033)

Thanks for the clarification! Since you’d mentioned IM administration it didn’t cross my mind that you were talking about Spravato. That typo is regrettable, but unimportant to your point that the nasal spray does indeed use two fixed doses.

[ Parent | on HN ]